Privia Health Group, Inc. (PRVA): EBITDA
$44.14M
Year ended 2025-12-31
$56.94M
Trailing 12 months to 2026-06-30
+10.1%
5-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $44.14M | +82.0% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $24.25M | -10.8% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $27.18M | n/m | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | -$14.55M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$214.97M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $27.22M | +55.7% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $17.49M | n/a | 2022-03-25, From 2019-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $44.14M | +82.0% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | -$186.14M | n/m |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $65.77M | +625.6% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $23.76M | n/m |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $60.42M | +36.6% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $109.07M | +33.5% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | -$3.48M | n/m |
| DocGo Inc. (DCGO) | 2025-12-31 | -$162.37M | n/m |
| Omada Health, Inc. (OMDA) | 2025-12-31 | -$6.48M | n/m |
Compare PRVA, PIII, LFST, INNV side by side · Screen every company in Services-Health Services ↗